Gabapentin is approved to treat seizures and postherpetic neuralgia, a type of nerve pain from shingles. It is thought to work by changing how nerves send messages to your brain. It is also used off-label to treat other neuropathic pain conditions. Neuropathic pain is a chronic debilitating pain syndrome that is complex to treat. Current medication management for neuropathic pain includes select neuromodulating agents such as anticonvulsants, serotonin norepinephrine reuptake inhibitors, tricyclic antidepressants, and certain opioids. 1,2 Gabapentin remains among the most commonly used anticonvulsants for neuropathic pain. Gabapentin at doses of 1800 mg to 3600 mg daily (1200 mg to 3600 mg gabapentin encarbil) can provide good levels of pain relief to some people with postherpetic neuralgia and peripheral diabetic neuropathy. Evidence for other types of neuropathic pain is very limited. A Cochrane review of gabapentin for chronic neuropathic pain in adults confirmed that gabapentin is associated with greater rates of pain relief compared with placebo in post-herpetic neuralgia and diabetic peripheral neuropathy, but it concluded that evidence for other neuropathic pain conditions was weak . The same review compared gabapentin to an inactive medicine (placebo) in almost 6,000 adults with chronic pain from PHN or diabetic neuropathy. Study participants were given either gabapentin or a placebo for 4 to at least 12 weeks. First-line drug therapy for painful diabetic peripheral neuropathy includes duloxetine, gabapentin, amitriptyline, and pregabalin; however, these medications do not restore sensation to affected extremities. Evidence for long-term benefit and safety of first-line treatment options is lacking. In animal models of analgesia, gabapentin prevents allodynia and hyperalgesia. Gabapentin is indicated for: Neuropathic pain caused by postherpetic neuralgia Adjunctive therapy in the treatment of partial seizures with or without secondary generalization; Neuropathic pain caused by diabetic peripheral neuropathy and spinal cord injury Pregabalin (Lyrica), gabapentin (Neurontin), amitriptyline (except in older adults), or duloxetine (Cymbalta) should be used as first-line treatment for painful diabetic peripheral neuropathy. A 1 Researchers publishing in JAMA Neurology describe the results of a unique trial in which 402 people with idiopathic sensory polyneuropathy were randomly assigned to one of four medications: duloxetine, mexiletine, nortriptyline, or pregabalin. Medicines such as gabapentin (Gralise, Neurontin, Horizant) and pregabalin (Lyrica), developed to treat epilepsy, often improve nerve pain. Side effects can include drowsiness and dizziness. Topical treatments. Lidocaine cream that is available without a prescription can be applied to the skin. Gabapentin was effective in the treatment of painful diabetic neuropathy, postherpetic neuralgia, and other neuropathic pain syndromes. It relieved symptoms of allodynia, burning pain, shooting pain, and hyperesthesia. Adverse effects were typically mild to moderate and usually subsided within approximately 10 days from the initiation of treatment. For immediate-release gabapentin (Neurontin), dosing may be initiated with 300 mg on day 1, doubled on day 2 (300 mg twice a day), and tripled on day 3 (300 mg 3 times a day). The dose can then be titrated up as needed for pain relief to a maximum dose of 1,800 mg daily (divided into 3 daily doses). to the editor: Contrary to the authors' statements, gabapentin (Neurontin) in dosages up to 3,600 mg per day is not more effective than placebo for the treatment of diabetic peripheral neuropathic Neurontin is an anti-epileptic drug, also called an anticonvulsant. It affects chemicals and nerves in the body that are involved in the cause of seizures and some types of pain. Neurontin is used in adults to treat neuropathic pain (nerve pain) caused by herpes virus or shingles (herpes zoster). Peripheral neuropathy is difficult to treat successfully; tricyclic antidepressants are effective at reducing pain, but intolerable side effects often limit their use. The anticonvulsant drug of choice is gabapentin (licensed indication for peripheral neuropathy, not licenced for central neuropathy). Capsules are the most cost-effective formulation. Where appropriate for patients with a low tablet/capsule load, using multiple capsules to make up a dose should be considered. Gabapentin at a dose of 1800 to 3600 mg daily (1200 to 3600 mg gabapentin encarbil) can provide good levels of pain relief to some people with postherpetic neuralgia and peripheral diabetic neuropathy. Gabapentin has an average rating of 6.3 out of 10 from a total of 185 reviews for the off-label treatment of Peripheral Neuropathy. 48% of reviewers reported a positive experience, while 24% reported a negative experience. Peripheral neuropathy is failure of the nerves that carry information to and from the brain and spinal cord. This produces symptoms like pain, loss of sensation, and inability to control muscles. Drugs used to treat Peripheral Neuropathy Neurontin, also known as gabapentin, is a medication that has been used to treat Peripheral Neuropathy symptoms. It’s a prescription medication that works by affecting the way that nerves send messages to the brain.
Articles and news, personal stories, interviews with experts.
Photos from events, contest for the best costume, videos from master classes.
![]() | ![]() |
![]() | ![]() |
![]() | ![]() |
![]() | ![]() |
![]() | ![]() |
![]() | ![]() |